[go: up one dir, main page]

IL286555A - Polymorphic and pseudopolymorphic forms of a pharmaceutical compound - Google Patents

Polymorphic and pseudopolymorphic forms of a pharmaceutical compound

Info

Publication number
IL286555A
IL286555A IL286555A IL28655521A IL286555A IL 286555 A IL286555 A IL 286555A IL 286555 A IL286555 A IL 286555A IL 28655521 A IL28655521 A IL 28655521A IL 286555 A IL286555 A IL 286555A
Authority
IL
Israel
Prior art keywords
polymorphic
pharmaceutical compound
pseudopolymorphic forms
pseudopolymorphic
forms
Prior art date
Application number
IL286555A
Other languages
Hebrew (he)
Other versions
IL286555B2 (en
IL286555B1 (en
Inventor
Sisir Bhattacharya
Alain Bonnet
Mahendra G Dedhiya
Alexandre Giuliani
Alain Priour
Valerie Ravaux
Peter Spargo
Veronique Ducandas
Original Assignee
Pfizer Ireland Pharmaceuticals
Sisir Bhattacharya
Alain Bonnet
Mahendra G Dedhiya
Alexandre Giuliani
Alain Priour
Valerie Ravaux
Peter Spargo
Veronique Ducandas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0904864A external-priority patent/FR2951171A1/en
Application filed by Pfizer Ireland Pharmaceuticals, Sisir Bhattacharya, Alain Bonnet, Mahendra G Dedhiya, Alexandre Giuliani, Alain Priour, Valerie Ravaux, Peter Spargo, Veronique Ducandas filed Critical Pfizer Ireland Pharmaceuticals
Publication of IL286555A publication Critical patent/IL286555A/en
Publication of IL286555B1 publication Critical patent/IL286555B1/en
Publication of IL286555B2 publication Critical patent/IL286555B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL286555A 2009-10-09 2010-10-08 Crystal of sodium salt of (1r,2s,5r)-7-oxo-6-sulfooxy-1,6-diazabicyclo[3.2.1]octane-2-carboxamide and pharmaceutical compositions thereof IL286555B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0904864A FR2951171A1 (en) 2009-10-09 2009-10-09 NOVEL SODIUM SALT OF A CRYSTALLIZED ENANTIOMER AZABICYCLIC COMPOUND AND NOVEL POLYMORPHIC AND PSEUDOPOLYMORPHIC FORMS AND THEIR PREPARATION
US26366309P 2009-11-23 2009-11-23
PCT/EP2010/065147 WO2011042560A1 (en) 2009-10-09 2010-10-08 Polymorphic and pseudopolymorphic forms of a pharmaceutical compound

Publications (3)

Publication Number Publication Date
IL286555A true IL286555A (en) 2021-10-31
IL286555B1 IL286555B1 (en) 2025-03-01
IL286555B2 IL286555B2 (en) 2025-07-01

Family

ID=71138449

Family Applications (1)

Application Number Title Priority Date Filing Date
IL286555A IL286555B2 (en) 2009-10-09 2010-10-08 Crystal of sodium salt of (1r,2s,5r)-7-oxo-6-sulfooxy-1,6-diazabicyclo[3.2.1]octane-2-carboxamide and pharmaceutical compositions thereof

Country Status (2)

Country Link
HK (1) HK1244484B (en)
IL (1) IL286555B2 (en)

Also Published As

Publication number Publication date
IL286555B2 (en) 2025-07-01
IL286555B1 (en) 2025-03-01
HK1244484B (en) 2019-11-08

Similar Documents

Publication Publication Date Title
IL239663A0 (en) Polymorphic and pseudopolymorphic forms of a pharmaceutical compound
EP2485589A4 (en) HETEROARYARY INHIBITORS OF BTK
EP2418213A4 (en) DERIVATIVE OF NEUROMEDIN U
EP2488146A4 (en) LABELING OF MEDICINE
DOP2012000114A (en) BROMODOMINIUM INHIBITOR OF BENZODIAZEPINA
BR112012014162A2 (en) manufacturing method of a nanomanta
SMT201500268B (en) DERIVATIVE OF 5-HYDROXYPIRYMIDIN-4-CARBOSSAMIDE
BR112012003435A2 (en) anhydrous forms of a pyridine derivative
IT1398296B1 (en) ARRANGEMENT OF SENSORS
EP2423204A4 (en) THIAZOLIDINONE DERIVATIVE
IL286555A (en) Polymorphic and pseudopolymorphic forms of a pharmaceutical compound
UY33133A (en) NEW DERIVATIVES OF PIRIDAZINA
BR112012013671A2 (en) halogenated derivatives of fty720
UA19624S (en) SET OF LABELS
UA19072S (en) SET OF LABELS
UA20171S (en) SET OF LABELS
UA18921S (en) SET OF LABELS
UA18663S (en) SET OF LABELS
UA19785S (en) DISPLAY OF PACKAGING
UA19947S (en) DISPLAY OF PACKAGING
UA19572S (en) DISPLAY OF PACKAGING
UA19666S (en) DISPLAY OF PACKAGING
UA19667S (en) DISPLAY OF PACKAGING
UA19686S (en) DISPLAY OF PACKAGING
UA19758S (en) DISPLAY OF PACKAGING